• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

李-弗劳梅尼综合征家族中的非小细胞肺癌不同变体:病例报告

Distinct NSCLC Variants in a Family With Li-Fraumeni Syndrome: Case Report.

作者信息

Edmondson Shelby, von Itzstein Mitchell S, Reys Brian, Mayer Melissa, Gagan Jeffrey, Gerber David E

机构信息

UT Southwestern Medical School, Dallas, Texas.

Department of Internal Medicine (Division of Hematology-Oncology), University of Texas Southwestern Medical Center, Dallas, Texas.

出版信息

JTO Clin Res Rep. 2022 Jun 25;3(8):100368. doi: 10.1016/j.jtocrr.2022.100368. eCollection 2022 Aug.

DOI:10.1016/j.jtocrr.2022.100368
PMID:35875466
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9304605/
Abstract

INTRODUCTION

Heritable lung cancer may occur in the context of germline mutations (Li-Fraumeni syndrome). Limited cases of intrafamily tumor genomic characteristics have been reported.

MAIN CONCERNS IMPORTANT CLINICAL FINDINGS PRIMARY DIAGNOSES INTERVENTIONS OUTCOMES

A 40-year-old woman with no smoking history or known environmental exposure risk was incidentally found to have stage II (T2N1) NSCLC harboring an exon 19 p.Glu746_Ala750 deletion. Family history was notable for an identical twin sister with colorectal cancer (diagnosed at age 31 y) and a mother with stage I NSCLC harboring an exon 21 c.2573T>G (p.Leu858Arg) mutation (diagnosed at age 69 y). Genetic testing revealed a germline c.542G>A (p.Arg181His) mutation in the patient, her mother, and her sister, consistent with Li-Fraumeni syndrome. No germline mutations were detected.

CONCLUSION

Shared germline mutations may be associated with distinct NSCLC somatic mutations within families with Li-Fraumeni syndrome. Further understanding of the association between genetic cancer syndromes and lung cancer risk may improve early lung cancer detection in populations not otherwise meeting screening eligibility.

摘要

引言

遗传性肺癌可能发生在种系突变(李-弗劳梅尼综合征)的背景下。关于家族内肿瘤基因组特征的病例报道有限。

主要关注点 重要临床发现 主要诊断 干预措施 结果:一名40岁女性,无吸烟史且无已知环境暴露风险,偶然发现患有II期(T2N1)非小细胞肺癌,伴有外显子19 p.Glu⁷⁴⁶_Ala⁷⁵⁰缺失。家族史值得注意的是,她有一个同卵双胞胎姐妹患结直肠癌(31岁时确诊),还有一位母亲患I期非小细胞肺癌,伴有外显子21 c.2573T>G(p.Leu⁸⁵⁸Arg)突变(69岁时确诊)。基因检测显示患者、其母亲和姐妹存在种系c.542G>A(p.Arg¹⁸¹His)突变,符合李-弗劳梅尼综合征。未检测到种系突变。

结论

在李-弗劳梅尼综合征家族中,共享的种系突变可能与不同的非小细胞肺癌体细胞突变相关。进一步了解遗传性癌症综合征与肺癌风险之间的关联,可能会改善在其他不符合筛查条件人群中的早期肺癌检测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c79f/9304605/d0517025fa57/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c79f/9304605/a95dd5ee70e6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c79f/9304605/d0517025fa57/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c79f/9304605/a95dd5ee70e6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c79f/9304605/d0517025fa57/gr2.jpg

相似文献

1
Distinct NSCLC Variants in a Family With Li-Fraumeni Syndrome: Case Report.李-弗劳梅尼综合征家族中的非小细胞肺癌不同变体:病例报告
JTO Clin Res Rep. 2022 Jun 25;3(8):100368. doi: 10.1016/j.jtocrr.2022.100368. eCollection 2022 Aug.
2
High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome.非小细胞肺癌和李-佛美尼综合征患者中体细胞致癌驱动基因改变的高发生率。
J Thorac Oncol. 2020 Jul;15(7):1232-1239. doi: 10.1016/j.jtho.2020.03.005. Epub 2020 Mar 14.
3
Molecular diagnosis and clinical outcome of a lung cancer patient with -E285K mutated Li-Fraumeni syndrome harboring a somatic -KDD mutation.一名患有携带体细胞-KDD突变的-E285K突变型李-弗劳梅尼综合征肺癌患者的分子诊断及临床结果
Am J Transl Res. 2020 Oct 15;12(10):6689-6693. eCollection 2020.
4
Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis.基于国际胚系 TP53 变异数据集中的 Li-Fraumeni 谱分析:国际癌症研究机构 TP53 数据库分析。
JAMA Oncol. 2021 Dec 1;7(12):1800-1805. doi: 10.1001/jamaoncol.2021.4398.
5
Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study.基于人群的 TP53 突变对早发性乳腺癌亚组的贡献估计:澳大利亚乳腺癌家族研究。
Cancer Res. 2010 Jun 15;70(12):4795-800. doi: 10.1158/0008-5472.CAN-09-0851. Epub 2010 May 25.
6
EGFR-mutated lung cancer as a secondary neoplasm in a patient with Li-Fraumeni syndrome: case report.表皮生长因子受体(EGFR)突变的肺癌作为李-佛美尼综合征患者的继发肿瘤:病例报告
AME Case Rep. 2024 Jun 14;8:76. doi: 10.21037/acr-23-206. eCollection 2024.
7
A case series of non-small cell lung cancer patients with or exon 20 insertion in Li Fraumeni syndrome.Li Fraumeni 综合征中存在外显子 20 插入的非小细胞肺癌患者的病例系列。
Tumori. 2024 Dec;110(6):NP5-NP10. doi: 10.1177/03008916241255485. Epub 2024 May 23.
8
Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.《结肠癌家族登记处早发性结直肠癌患者的胚系 TP53 突变》
JAMA Oncol. 2015 May;1(2):214-21. doi: 10.1001/jamaoncol.2015.0197.
9
A dual biomarker in non-small cell lung cancer that predicts Li Fraumeni syndrome : Lung cancer and Li Fraumeni.非小细胞肺癌中的双重生物标志物可预测 Li Fraumeni 综合征:肺癌与 Li Fraumeni。
Fam Cancer. 2024 Nov;23(4):469-471. doi: 10.1007/s10689-024-00418-8. Epub 2024 Sep 5.
10
Does PTEN gene mutation play any role in Li-Fraumeni syndrome.PTEN基因突变在李-弗劳梅尼综合征中起作用吗?
Med J Islam Repub Iran. 2016 May 29;30:378. eCollection 2016.

引用本文的文献

1
EGFR-mutated lung cancer as a secondary neoplasm in a patient with Li-Fraumeni syndrome: case report.表皮生长因子受体(EGFR)突变的肺癌作为李-佛美尼综合征患者的继发肿瘤:病例报告
AME Case Rep. 2024 Jun 14;8:76. doi: 10.21037/acr-23-206. eCollection 2024.
2
Characterization of Incidental Pathogenic Germline Findings Detected via ctDNA among Patients with Non-Small Cell Lung Cancer in a Predominantly Hispanic/Latinx Population.在以西班牙裔/拉丁裔为主的人群中,通过循环肿瘤DNA(ctDNA)检测到的非小细胞肺癌患者偶然致病性种系发现的特征分析
Cancers (Basel). 2024 Mar 14;16(6):1150. doi: 10.3390/cancers16061150.

本文引用的文献

1
High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome.非小细胞肺癌和李-佛美尼综合征患者中体细胞致癌驱动基因改变的高发生率。
J Thorac Oncol. 2020 Jul;15(7):1232-1239. doi: 10.1016/j.jtho.2020.03.005. Epub 2020 Mar 14.
2
Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population.墨西哥早发性乳腺癌患者中 TP53 基因种系突变的流行率。
BMC Cancer. 2019 Feb 1;19(1):118. doi: 10.1186/s12885-019-5312-2.
3
Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome.
Li-Fraumeni 综合征患者的癌症筛查建议。
Clin Cancer Res. 2017 Jun 1;23(11):e38-e45. doi: 10.1158/1078-0432.CCR-17-0408.
4
Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition.李-佛美尼综合征:理解遗传性癌症易感性的范例。
Br J Haematol. 2017 Feb;176(4):539-552. doi: 10.1111/bjh.14461. Epub 2016 Dec 16.
5
EGFR-mutated lung cancer in Li-Fraumeni syndrome.李-佛美尼综合征中的表皮生长因子受体(EGFR)突变型肺癌
Lung Cancer. 2014 Sep;85(3):485-7. doi: 10.1016/j.lungcan.2014.06.017. Epub 2014 Jun 30.
6
Familial risk of lung carcinoma in the Icelandic population.冰岛人群中肺癌的家族风险。
JAMA. 2004 Dec 22;292(24):2977-83. doi: 10.1001/jama.292.24.2977.